CITED2
CITED2 (Cbp/p300-interacting transactivator 2, also known as MRG1) is a nuclear transcriptional coregulator of the CITED family. It acts through the p300/CBP coactivator complex, where it can either enhance or restrain transcription depending on the partner transcription factor. Browse Assay Genie's current range of CITED2 research reagents below, or read on for the biology behind the target.
CITED2 is a transcriptional coactivator of the p300/CBP-mediated transcription complex. It acts as a bridge, linking TFAP2 transcription factors to p300/CBP to stimulate TFAP2-mediated transcriptional activation. It also positively regulates TGF-beta signalling through its association with the SMAD/p300/CBP coactivator complex, stimulates the transcriptional activity of the peroxisome proliferator-activated receptor PPARA, and enhances oestrogen-dependent transactivation mediated by oestrogen receptors.
The protein can also act as a corepressor. It interferes with the binding of HIF1A or STAT2 to the p300/CBP coactivator complex, and NCBI describes it as inhibiting transactivation of HIF1A-induced genes by competing with hypoxia-inducible factor 1-alpha for binding to p300-CH1. This dual behaviour makes CITED2 a useful node for studying how limited pools of p300/CBP are allocated between competing transcription factors.
In development, CITED2 participates in sex determination and early gonad development by stimulating transcription of SRY. It helps control left-right patterning during embryogenesis by potentiating NODAL-mediated gene transcription in the left lateral plate mesoderm. It is also essential for differentiation of the adrenal cortex from the adrenogonadal primordium, where it stimulates WT1-mediated activation of the NR5A1 promoter, and it associates with chromatin at the PITX2 P1 promoter region.
The CITED2 gene was previously named for its Glu/Asp-rich carboxy-terminal domain and is also known as MRG1. Mutations in the gene are a cause of cardiac septal defects, and alternatively spliced transcript variants encoding multiple isoforms have been observed. The mouse ortholog is Cited2.
CITED2 bridges transcription factors such as TFAP2 and SMAD complexes to p300/CBP, making it a model for coactivator-dependent gene regulation.
CITED2 competes with HIF1A for p300-CH1 binding and inhibits HIF1A-induced gene transactivation, relevant to studies of the hypoxic response.
CITED2 contributes to left-right patterning, gonad development and adrenal cortex differentiation, through NODAL, SRY and WT1-NR5A1 regulation.
Mutations in the CITED2 gene are a cause of cardiac septal defects, linking the protein to cardiac developmental research.
CITED2 is a nuclear coregulator that works with the p300/CBP complex. It bridges TFAP2 factors to p300/CBP, supports TGF-beta/SMAD, PPARA and oestrogen receptor activity, and can repress HIF1A or STAT2 by interfering with their binding to p300/CBP.
CITED2 is also known as MRG1, and earlier names refer to its Glu/Asp-rich carboxy-terminal domain. It belongs to the CITED family. NCBI reports that alternatively spliced transcript variants encode multiple isoforms of the protein.
Mutations in the CITED2 gene are a cause of cardiac septal defects. The mouse ortholog, Cited2, is also a recognised gene. Check the datasheet of any product for its validated reactivity.
Transcription factors, p300/CBP coactivators and developmental regulators that interact with CITED2 in hypoxia, TGF-beta and gonad development pathways.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q99967; product specifications from Assay Genie datasheets.